Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
13.63
+0.75 (5.82%)
At close: May 3, 2024, 4:00 PM
13.69
+0.06 (0.44%)
After-hours: May 3, 2024, 7:55 PM EDT
Iovance Biotherapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$25.64
Upside
+88.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +39.40% | Mar 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $26 | Strong Buy | Maintains | $17 → $26 | +90.76% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +134.78% | Mar 4, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +83.42% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +134.78% | Feb 29, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +54.07% | Feb 29, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $22 | Buy | Maintains | $18 → $22 | +61.41% | Feb 29, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $19 | Strong Buy | Maintains | $13 → $19 | +39.40% | Feb 21, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $25 | Buy | Maintains | $18 → $25 | +83.42% | Feb 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | +61.41% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $19 | Strong Buy | Maintains | $13 → $19 | +39.40% | Feb 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $18 | Buy | Maintains | $14 → $18 | +32.06% | Feb 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $29 → $34 | Strong Buy | Maintains | $29 → $34 | +149.45% | Feb 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $28 | Strong Buy | Maintains | $38 → $28 | +105.43% | Dec 27, 2023 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +24.72% | Dec 27, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | -11.96% | Nov 20, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $28 | Strong Buy | Maintains | $38 → $28 | +105.43% | Nov 8, 2023 |
| Barclays | Barclays | Buy Maintains $40 → $18 | Buy | Maintains | $40 → $18 | +32.06% | Sep 18, 2023 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +24.72% | Sep 15, 2023 |
| Mizuho | Mizuho | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +120.10% | Sep 15, 2023 |
| Stifel | Stifel | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +83.42% | Sep 15, 2023 |